Cover Image

The BALB/c.mdx62 mouse exhibits a dystrophic muscle pathology and is a model of Duchenne muscular dystrophy

Saved in:

Bibliographic Details
Main Authors:	Kristy Swiderski (Author), Audrey S. Chan (Author), Marco J. Herold (Author), Andrew J. Kueh (Author), Jin D. Chung (Author), Justin P. Hardee (Author), Jennifer Trieu (Author), Annabel Chee (Author), Timur Naim (Author), Paul Gregorevic (Author), Gordon S. Lynch (Author)
Format:	Book
Published:	The Company of Biologists, 2024-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Iron overload and impaired iron handling contribute to the dystrophic pathology in models of Duchenne muscular dystrophy
by: Francesca M. Alves, et al.
Published: (2022)

Emotional behavior and brain anatomy of the mdx52 mouse model of Duchenne muscular dystrophy
by: Amel Saoudi, et al.
Published: (2021)

In vivo cerebellar circuit function is disrupted in an mdx mouse model of Duchenne muscular dystrophy
by: Trace L. Stay, et al.
Published: (2020)

Preclinical Studies in the mdx Mouse Model of Duchenne Muscular Dystrophy with the Histone Deacetylase Inhibitor Givinostat
by: Silvia Consalvi, et al.
Published: (2013)

The Effect of Vitamin D Supplementation on Skeletal Muscle in the <i>mdx</i> Mouse Model of Duchenne Muscular Dystrophy
by: Danielle A. Debruin, et al.
Published: (2019)

A Blood Biomarker for Duchenne Muscular Dystrophy Shows That Oxidation State of Albumin Correlates with Protein Oxidation and Damage in Mdx Muscle
by: Basma A. Al-Mshhdani, et al.
Published: (2021)

Genetic analysis of 62 Chinese families with Duchenne muscular dystrophy and strategies of prenatal diagnosis in a single center
by: Jingjing Zhang, et al.
Published: (2019)

Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (1989)

Prednisone in Duchenne Dystrophy
by: J Gordon Millichap
Published: (1991)

Levels of α7 integrin and laminin-α2 are increased following prednisone treatment in the mdx mouse and GRMD dog models of Duchenne muscular dystrophy
by: Ryan D. Wuebbles, et al.
Published: (2013)

Metabolic remodeling of dystrophic skeletal muscle reveals biological roles for dystrophin and utrophin in adaptation and plasticity
by: Justin P. Hardee, et al.
Published: (2021)

Theragnosis for Duchenne Muscular Dystrophy
by: Leonela Luce, et al.
Published: (2021)

Serum Transaminase in Duchenne Dystrophy
by: J Gordon Millichap
Published: (2011)

Muscular Fatigue in Duchenne Dystrophy
by: J Gordon Millichap
Published: (1995)

Brain Dystrophin in Duchenne Dystrophy
by: J Gordon Millichap
Published: (1995)

Genetics of Duchenne and Becker Dystrophies
by: J Gordon Millichap
Published: (1990)

Prednisone Therapy for Duchenne Dystrophy
by: J Gordon Millichap
Published: (2005)

Glucocorticoids for Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (2013)

A Reduction in Selenoprotein S Amplifies the Inflammatory Profile of Fast-Twitch Skeletal Muscle in the mdx Dystrophic Mouse
by: Craig Robert Wright, et al.
Published: (2017)

Dystrophic muscle distribution in late-stage muscular dystrophy
by: Celeste Michelle Pilato, et al.
Published: (2021)

Eteplirsen in the treatment of Duchenne muscular dystrophy
by: Lim KRQ, et al.
Published: (2017)

Cognition in Duchenne Dystrophy and Mutation Site
by: J Gordon Millichap
Published: (2011)

Brain Function in Duchenne Muscular Dystrophy
by: J. Gordon Millichap
Published: (2002)

Early Development in Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (1990)

Delay in Diagnosis of Duchenne Muscular Dystrophy
by: Vamshi K Rao, et al.
Published: (2015)

Prednisone-Treated Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (1991)

Language Delay in Duchenne's Muscular Dystrophy
by: J Gordon Millichap
Published: (2007)

BREAKTHROUGH IN DUCHENNE MUSCULAR DYSTROPHY TREATMENT
by: article Editorial
Published: (2022)

Clinical-evolutionary considerations in Duchenne Dystrophy
by: Cristina Elena Singer, et al.
Published: (2023)

Poly(ester amine) Composed of Polyethylenimine and Pluronic Enhance Delivery of Antisense Oligonucleotides In Vitro and in Dystrophic mdx Mice
by: Mingxing Wang, et al.
Published: (2016)

Mechanisms of chemotherapy‐induced muscle wasting in mice with cancer cachexia
by: Kate T. Murphy, et al.
Published: (2022)

Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia
by: Kate T. Murphy, et al.
Published: (2012)

A Novel MAO-B/SSAO Inhibitor Improves Multiple Aspects of Dystrophic Phenotype in <i>mdx</i> Mice
by: Francesca Gasparella, et al.
Published: (2024)

RhoA/ROCK signalling activated by ARHGEF3 promotes muscle weakness via autophagy in dystrophic mdx mice
by: Jae‐Sung You, et al.
Published: (2023)

Drug development progress in duchenne muscular dystrophy
by: Jiexin Deng, et al.
Published: (2022)

CARDIAC COMPLICATIONS IN DUCHENNE MUSCULAR DYSTROPHY IN CHILDREN
by: Ioana Grigore, et al.
Published: (2015)

Scaling up research for Duchenne muscular dystrophy
Published: (2021)

Oxidised Albumin Levels in Plasma and Skeletal Muscle as Biomarkers of Disease Progression and Treatment Efficacy in Dystrophic <i>mdx</i> Mice
by: Jessica R. Terrill, et al.
Published: (2024)

Precision Medicine and Exercise Therapy in Duchenne Muscular Dystrophy
by: Matthew Kostek
Published: (2019)

Nitric Oxide (NO) and Duchenne Muscular Dystrophy: NO Way to Go?
by: Cara A. Timpani, et al.
Published: (2020)